$lfmd

$LFMD sees a surge in social engagement driven by X, with [---] interactions in 24h. Discussions highlight strong fundamentals and industry growth, but also concerns over stock underperformance relative to key partners.

About $lfmd

$LFMD is a digital platform focused on user interaction and content sharing, particularly within the healthcare and telehealth sector.

Engagements: [---] (24h)

Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [------]
[--] Month: [------] -72%
[--] Months: [---------] -68%
[--] Year: [---------] +67%
1-Year High: [-------] on 2025-11-17
1-Year Low: [---] on 2026-01-04

Engagements by network (24h): Reddit: [--] X: [---] YouTube: [--]

Mentions: [--] (24h)

Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-10-09

Mentions by network (24h): Reddit: [--] X: [--] YouTube: [--]

Creators: [--] (24h)

Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $lfmd in the last [--] hours which is up 2.90% from [--] in the previous [--] hours Daily Average: [--]
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-04-05

The most influential creators that mention $lfmd in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@ValueNotDeadYet	[--]	[-----]	[--]	[---]
@CapitalVennett	[--]	[---]	[--]	[---]
@BigUpsideStocks	[--]	[---]	[--]	[--]
@TeleHInvesting	[--]	[---]	[--]	[--]
@SFarringtonBKC	[--]	[-----]	[--]	[--]

View More

Sentiment: 80%

Sentiment 24-Hour Time-Series Raw Data
Current Value: 80%
Daily Average: 78%
[--] Month: 39% -26%
[--] Months: 39% -26%
[--] Year: 39% -46%
1-Year High: 100% on 2025-02-19
1-Year Low: 6% on 2026-02-06

Most Supportive Themes:

• Strong Fundamentals and Partnerships: (50%) The company is highlighted for its strong financial metrics, including a low P/S ratio, high gross margin, significant cash reserves, and no debt, alongside strategic partnerships with major players like Eli Lilly ($LLY) and Novo Nordisk ($NVO).
• Industry Growth and Potential: (25%) The telehealth sector is experiencing significant CAGR, and the company is positioned to benefit from this growth, with expectations of positive stock performance driven by subscriber growth in oral GLP-1.

Most Critical Themes:

• Underperformance Relative to Partners: (50%) Despite strong sales from partners like Novo Nordisk ($NVO) for Wegovy, the company's stock is performing poorly, leading to confusion and questions about market dynamics.

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing